Both agents synergistically reduced Vascular Endothelial Growth Factor (TFRC) expression and the concomitant degradation of Ferritin light chain (FTL) and ferritin heavy chain (FTH), thus promoting HCC cells toward ferroptosis [137]. The gene discussed is FTL; the disease is hepatocellular carcinoma.